Speaker Details

Brett King, MD, PhD, FAAD

Brett King, MD, PhD, FAAD

SESSIONS

S008 Update in General Dermatology
Mar 27, 2026 • 9:00 AM - 12:00 PM • Four Seasons 3
S025 JAK Inhibitors: A New Frontier in Dermatology
Mar 28, 2026 • 9:00 AM - 12:00 PM • Bluebird 1A
U093 JAAD Game Changers
Mar 30, 2026 • 7:30 AM - 8:30 AM • Bluebird 2D
F086 Alopecia Areata: New Therapies
Mar 30, 2026 • 1:00 PM - 3:00 PM • Mile High 4A

DISCLOSURES

AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);